多聚血红蛋白-超氧化物歧化酶-过氧化氢酶-碳酸酐酶：一种基于生物技术的新型血液替代品，可运输氧气和二氧化碳，并具有抗氧化作用。
Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
作者信息
Bian Yuzhu, Rong Zhixia, Chang Thomas Ming Swi
机构信息
Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
出版信息
Artif Cells Blood Substit Immobil Biotechnol. 2011 Jun;39(3):127-36. doi: 10.3109/10731199.2011.581052.
Abstract
Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase (PolyHb-SOD-CAT-CA) is a therapeutic antioxidant that also transports both oxygen and carbon dioxide. This is formed by crosslinking Hb with SOD, CAT, and CA using glutaraldehyde. Crosslinking stroma free Hb from red blood cell (rbc) reduces CA activity to 55%. Addition of more CA resulted in a preparation with the same CA activity as RBC. PolyHb in the complex acts as a buffer to prevent large pH changes as carbon dioxide is converted to carbonic acid. We then prepare and optimize a novel PolyHb-SOD-CAT-CA, a therapeutic antioxidant that also transports both oxygen and carbon dioxide.
摘要
多聚血红蛋白-超氧化物歧化酶-过氧化氢酶-碳酸酐酶（PolyHb-SOD-CAT-CA）是一种兼具治疗作用的抗氧化剂，同时还能运输氧气和二氧化碳。它是通过戊二醛将血红蛋白与超氧化物歧化酶、过氧化氢酶和碳酸酐酶交联而成的。将红细胞（rbc）中的无基质血红蛋白进行交联会使碳酸酐酶活性降低至55%。添加更多的碳酸酐酶可得到一种碳酸酐酶活性与红细胞相同的制剂。复合物中的多聚血红蛋白起到缓冲作用，防止二氧化碳转化为碳酸时pH值发生大幅变化。然后，我们制备并优化了一种新型的PolyHb-SOD-CAT-CA，它是一种兼具治疗作用的抗氧化剂，同时还能运输氧气和二氧化碳。
相似文献
1
Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
Artif Cells Blood Substit Immobil Biotechnol. 2011 Jun;39(3):127-36. doi: 10.3109/10731199.2011.581052.
2
Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
Artif Cells Blood Substit Immobil Biotechnol. 2012 Feb;40(1-2):28-37. doi: 10.3109/10731199.2011.582041. Epub 2011 Jun 21.
3
Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties.
Artif Cells Nanomed Biotechnol. 2013 Feb;41(1):60-8. doi: 10.3109/10731199.2013.745291.
4
Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at -80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C.
Artif Cells Nanomed Biotechnol. 2016;44(1):41-7. doi: 10.3109/21691401.2015.1110871. Epub 2015 Nov 27.
5
A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume.
Artif Cells Nanomed Biotechnol. 2015 Feb;43(1):1-9. doi: 10.3109/21691401.2014.964554. Epub 2014 Oct 9.
6
Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.
Artif Cells Nanomed Biotechnol. 2013 Aug;41(4):232-9. doi: 10.3109/21691401.2012.751180. Epub 2013 Jan 22.
7
Preliminary Study on Polymerization between Hemoglobin and Enzymes during the Preparation of PolyHb-SOD-CAT-CA.
Dokl Biochem Biophys. 2024 Oct;518(1):463-474. doi: 10.1134/S1607672924600477. Epub 2024 Aug 28.
8
Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase.
Artif Cells Nanomed Biotechnol. 2015 Jun;43(3):157-62. doi: 10.3109/21691401.2015.1035479. Epub 2015 May 11.
9
Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.
Nat Biotechnol. 1998 Jul;16(7):667-71. doi: 10.1038/nbt0798-667.
10
From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.
Artif Cells Blood Substit Immobil Biotechnol. 2012 Jun;40(3):197-9. doi: 10.3109/10731199.2012.662408. Epub 2012 Mar 13.
引用本文的文献
1
Advanced delivery systems for oxygen therapeutics: center around red blood cells.
Ther Deliv. 2025 May;16(5):501-509. doi: 10.1080/20415990.2025.2475737. Epub 2025 Mar 9.
2
Engineering Synthetic Erythrocytes as Next-Generation Blood Substitutes.
Adv Funct Mater. 2024 Jul 10;34(28). doi: 10.1002/adfm.202315879. Epub 2024 Feb 8.
3
Controlled oxygen delivery to power tissue regeneration.
Nat Commun. 2024 May 22;15(1):4361. doi: 10.1038/s41467-024-48719-x.
4
Development of novel polymer haemoglobin based particles as an antioxidant, antibacterial and an oxygen carrier agents.
Sci Rep. 2024 Feb 6;14(1):3031. doi: 10.1038/s41598-024-53548-5.
5
Hemoglobin-stabilized gold nanoclusters displaying oxygen transport ability, self-antioxidation, auto-fluorescence properties and long-term storage potential.
RSC Adv. 2023 May 23;13(23):15540-15553. doi: 10.1039/d3ra00689a. eCollection 2023 May 22.
6
Emerging trends in environmental and industrial applications of marine carbonic anhydrase: a review.
Bioprocess Biosyst Eng. 2022 Mar;45(3):431-451. doi: 10.1007/s00449-021-02667-8. Epub 2021 Nov 25.
7
Glutaraldehyde-Polymerized Hemoglobin: In Search of Improved Performance as Oxygen Carrier in Hemorrhage Models.
Bioinorg Chem Appl. 2020 Sep 1;2020:1096573. doi: 10.1155/2020/1096573. eCollection 2020.
8
Artificial Blood: A Futuristic Dimension of Modern Day Transfusion Sciences.
Cardiovasc Hematol Agents Med Chem. 2019;17(1):11-16. doi: 10.2174/1871525717666190617120045.
9
Microbial Carbonic Anhydrases in Biomimetic Carbon Sequestration for Mitigating Global Warming: Prospects and Perspectives.
Front Microbiol. 2017 Aug 25;8:1615. doi: 10.3389/fmicb.2017.01615. eCollection 2017.
10
Acute kidney function and morphology following topload administration of recombinant hemoglobin solution.
Artif Cells Nanomed Biotechnol. 2017 Feb;45(1):24-30. doi: 10.1080/21691401.2016.1241795. Epub 2016 Oct 31.
本文引用的文献
1
Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jul-Aug;2(4):418-30. doi: 10.1002/wnan.95.
2
The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate.
Artif Cells Blood Substit Immobil Biotechnol. 2010 Apr;38(2):57-63. doi: 10.3109/10731191003634232.
3
Nanobiotechnology for hemoglobin-based blood substitutes.
Crit Care Clin. 2009 Apr;25(2):373-82, Table of Contents. doi: 10.1016/j.ccc.2008.12.006.
4
Electrometric and colorimetric determination of carbonic anhydrase.
J Biol Chem. 1948 Oct;176(1):147-54.
5
A modified colorimetric estimation of carbonic anhydrase.
Biochem J. 1936 Dec;30(12):2191-3. doi: 10.1042/bj0302191.
6
SEMIPERMEABLE MICROCAPSULES.
Science. 1964 Oct 23;146(3643):524-5. doi: 10.1126/science.146.3643.524.
7
The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable.
J Am Coll Surg. 2002 Oct;195(4):445-52; discussion 452-5. doi: 10.1016/s1072-7515(02)01335-2.
8
Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial.
J Thorac Cardiovasc Surg. 2002 Jul;124(1):35-42. doi: 10.1067/mtc.2002.121505.
9
Carbon dioxide transport and carbonic anhydrase in blood and muscle.
Physiol Rev. 2000 Apr;80(2):681-715. doi: 10.1152/physrev.2000.80.2.681.
10
Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.
Nat Biotechnol. 1998 Jul;16(7):667-71. doi: 10.1038/nbt0798-667.
Zotero 插件